Paroxetine Tablet, Film Coated
Product Images NDC 70518-3430

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 70518-3430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (9d3352de B6ab 4118 A714 54875d85b0c5 01)

Image (9d3352de B6ab 4118 A714 54875d85b0c5 01)
Chemical structure of paroxetine hydrochloride, showing the molecular arrangement including a fluorophenyl group, a piperidine ring, and a methylenedioxyphenyl moiety.*
FDA Label Image

Image (9d3352de B6ab 4118 A714 54875d85b0c5 02)

Image (9d3352de B6ab 4118 A714 54875d85b0c5 02)
A chart depicting fold changes and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of various interacting drugs relative to reference levels. The x-axis shows change relative to reference on a logarithmic scale from 0.1 to 10, with data points for Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg.*
FDA Label Image

Image (9d3352de B6ab 4118 A714 54875d85b0c5 03)

Image (9d3352de B6ab 4118 A714 54875d85b0c5 03)
A forest plot chart showing fold change and 90% confidence intervals for drug interactions affecting Paroxetine pharmacokinetics. Drugs listed with doses include Cimetidine, Phenobarbital, Phenytoin, Digoxin, and Diazepam. Variables depicted are Cmax and AUC fold changes relative to a reference, with plotted points and confidence bars for each interaction.*
FDA Label Image

Image (9d3352de B6ab 4118 A714 54875d85b0c5 04)

Image (9d3352de B6ab 4118 A714 54875d85b0c5 04)
A figure showing fold change and 90% confidence interval in pharmacokinetic parameters (Cmax, AUC, Cmin) for Paroxetine across different populations including renal impairment (mild, moderate, severe), hepatic impairment, elderly patients at various doses, and male gender. The horizontal axis shows change relative to reference on a logarithmic scale from 0.5 to 50.*
FDA Label Image

Paroxetine 10mg 70518 3430 01

Paroxetine 10mg 70518 3430 01
Label for Paroxetine 10 mg film-coated tablet by RemedyRepack Inc. The label shows tablet quantity of 30 and includes standard prescription information such as the NDC number 70518-3430-01, manufacturer details (Zydus Pharm, Pennington, NJ), storage instructions, and a barcode. The packaging specifies the product is Rx only and advises to keep out of reach of children.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Paroxetine 10 mg film-coated tablets label showing quantity of 90 tablets. The label includes the NDC number 70518-3430-00, manufacturer information (Zydus Pharm, Pennington, NJ), and repackager RemedyRepack Inc. Directions for use refer to the package insert. Storage instructions and warnings to keep medication out of reach of children are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.